
浏览全部资源
扫码关注微信
1.北京中医药大学中医学院 北京 100029
2.北京中医药大学中医药研究院
3.北京中医药大学中药学院
彭俙仪,女,在读硕士生
#王停,男,博士,教授,博士生导师,主要研究方向:中药毒性研究与中药新药研发,E-mail: wangting1973@sina.com
收稿日期:2024-05-20,
纸质出版日期:2024-11-30
移动端阅览
彭俙仪, 张林, 翟裕祺, 等. 基于“有故无殒”理论探究朝鲜淫羊藿对肾阳虚、肾阴虚证模型大鼠肝脏功能的影响[J]. 北京中医药大学学报, 2024,47(11):1562-1572.
PENG Xiyi, ZHANG Lin, ZHAI Yuqi, et al. The effects of
彭俙仪, 张林, 翟裕祺, 等. 基于“有故无殒”理论探究朝鲜淫羊藿对肾阳虚、肾阴虚证模型大鼠肝脏功能的影响[J]. 北京中医药大学学报, 2024,47(11):1562-1572. DOI: 10.3969/j.issn.1006-2157.2024.11.000.
PENG Xiyi, ZHANG Lin, ZHAI Yuqi, et al. The effects of
目的
2
基于“有故无殒”理论观察朝鲜淫羊藿对肾阳虚、肾阴虚及正常大鼠肝脏功能的影响,探究朝鲜淫羊藿致肝损伤与机体证候间的联系。
方法
2
采用随机数字表法将72只雄性SD大鼠分为正常组、肾阳虚组、肾阴虚组。肾阳虚组大鼠每日肌内注射氢化可的松注射液(20 mg/kg)建立肾阳虚证候模型,肾阴虚组大鼠每日灌胃甲状腺片混悬液(160 mg/kg)建立肾阴虚证候模型,连续14 d。造模成功后将大鼠按随机数字表法分为正常组,朝鲜淫羊藿低、高剂量组,肾阳虚组,肾阳虚+朝鲜淫羊藿低、高剂量组,肾阴虚组,肾阴虚+朝鲜淫羊藿低、高剂量组。药物组动物连续灌胃相应药物,朝鲜淫羊藿低剂量各组剂量为0.26 g/kg、朝鲜淫羊藿高剂量各组剂量为0.77 g/kg,其余组予饮用水,每日1次,连续28 d。给药期间监测大鼠体质量变化;给药结束后,采用生化分析仪检测各组大鼠血清碱性磷酸酶(ALP)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、直接胆红素(DBil)、间接胆红素(IBil)、总胆红素(TBil)含量;测量各组大鼠肝脏质量、计算脏体比及脏脑比;HE染色观察各组大鼠肝脏病理变化。
结果
2
与正常组比较,朝鲜淫羊藿高剂量组大鼠在给药第21天体质量降低,IBil升高(均
P
<
0.05);肾阳虚组大鼠第3~28天每个测量时间节点体质量均降低,ALP升高,肝脏质量降低(均
P
<
0.05)。与肾阳虚组比较,肾阳虚+朝鲜淫羊藿高剂量组大鼠ALP降低(均
P
<
0.05),肾阳虚各给药组大鼠肝组织病理损伤情况有所改善,脂肪空泡情况减少,病理评分有降低趋势。与肾阴虚组比较,肾阴虚+朝鲜淫羊藿高剂量组大鼠IBil升高,脏脑比降低(均
P
<
0.05)。
结论
2
在研究剂量范围内,朝鲜淫羊藿对肾阳虚证大鼠肝功能影响较小,对正常大鼠及肾阴虚证大鼠有一定致肝损伤作用,朝鲜淫羊藿致肝损伤与证候间可能存在相关性。
Objective
2
This study explored the effects of
Epimedium koreanum
Nakai (EK) on liver function in normal
kidney yang deficiency (KYANGDS)
and
kidney yin deficiency (KYINDS) rats based on the theory of " You Gu Wu Yun." The study also investigated the connection between EK-induced liver injury and symptoms.
Methods
2
Seventy-two male SD rats were divided into normal
KYANGDS
and KYINDS groups using the random number table method. The KYANGDS model was established through intramuscular injection of 20 mg/kg of hydrocortisone
whereas the KYINDS model was established through daily gavage of 160 mg/kg of thyroid tablet suspension for 14 consecutive days. After successful modeling
the rats were divided into the normal
EK low-dose
EK high-dose
KYANGDS
KYANGDS + EK low-dose
KYANGDS + EK high-dose
KYINDS
KYINDS + EK low-dose
and KYINDS + EK high-dose groups using the random number table method. Animals in the drug groups were administered low (0.26 g/kg) and high (0.77 g/kg) EK extract doses through continuous gavage. The other groups received drinking water once a day for 28 consecutive days. Changes in body mass were monitored during the administration period
and serum alkaline phosphatase (ALP)
alanine transaminase(ALT)
aspartate transaminase(AST)
direct bilirubin
indirect bilirubin (IBil)
and total bilirubin (TBil) were measured at the end of administration using biochemical analyzers. The liver weight
visceral body ratio
and visceral brain ratio were measured. Hematoxylin and eosin staining were performed to observe the pathological changes in the liver.
Results
2
Compared with the normal group
the EK high-dose group showed a decrease in body weight on the 21st day during the drug administration period and an increase in IBil (
P
<
0.05); the KYANGDS group had lower body weight at each measurement time point from the third to the 28th day
higher ALP
and lower liver weight (
P
<
0.05). Compared with the KYANGDS group
the KYANGDS + EK high-dose group had decreased ALP levels (
P
<
0.05). The pathological damage of liver tissue
in each KYANGDS administration group improved
the presence of fat vacuoles were reduced
and pathological scores show a decreasing trend. Compared with the KYINDS group
KYINDS+ EK high-dose group exhibited a higher IBil level and a lower visceral brain ratio(
P
<
0.05).
Conclusion
2
EK has a small effect on the liver function of rats with KYANGDS within the dose range; however
it has a specific hepatogenic impact on normal and KYINDS rats
and EK-induced liver injury and the symptoms may be associated with each other.
国家药典委员会 . 中华人民共和国药典·一部:2020年版 [M ] . 北京 : 中国医药科技出版社 , 2020 .
姜涛 , 凌翠敏 , 陈庆真 , 等 . 淫羊藿苷通过提高自噬促进成骨细胞分化防治骨质疏松 [J ] . 中国组织工程研究 , 2021 , 25 ( 17 ): 2643 - 2649 .
XIE F , WU CF , LAI WP , et al . The osteoprotective effect of Herba Epimedii (HEP) extract in vivo and in vitro [J ] . Evid Based Complement Alternat Med , 2005 , 2 ( 3 ): 353 - 361 .
高学勇 , 林珊 , 韩咪莎 . 淫羊藿苷对环磷酰胺诱导生精障碍大鼠下丘脑-垂体-睾丸轴的影响 [J ] . 解剖学杂志 , 2018 , 41 ( 2 ): 147 - 151 .
丁越 , 徐晓宇 , 王亚非 , 等 . 淫羊藿生物碱对环磷酰胺引起的雄鼠生殖系统损伤的保护作用 [J ] . 食品工业科技 , 2021 , 42 ( 21 ): 353 - 360 .
WANG YL , SHANG C , ZHANG Y , et al . Regulatory mechanism of icariin in cardiovascular and neurological diseases [J ] . Biomed Pharmacother , 2023 , 158 : 114156 .
付舒 , 李叶丽 , 吴雨婷 , 等 . 淫羊藿次苷Ⅱ通过调节MMP-2、MMP-9和TIMP-1的表达抗自发性高血压大鼠心肌纤维化 [J ] . 中国药理学通报 , 2018 , 34 ( 9 ): 1253 - 1257 .
贺琴 , 谭华炳 . 淫羊藿致HBV携带者发生肝脏损害1例 [J ] . 中国肝脏病杂志(电子版) , 2015 , 7 ( 1 ): 113 - 114 .
赵永康 , 刘雨旸 , 石伟 , 等 . 淫羊藿制剂相关肝损伤临床特征及潜在风险因素分析 [J ] . 中国实验方剂学杂志 , 2024 , 30 ( 6 ): 205 - 210 .
CFDA . CFDA:警惕仙灵骨葆口服制剂引起的肝损伤风险 [J ] . 上海医药 , 2017 , 38 ( 1 ): 80 .
杨小聪 , 姚晨 . 10例仙灵骨葆胶囊致肝损伤病例的临床分析及其治疗措施 [J ] . 抗感染药学 , 2021 , 18 ( 9 ): 1366 - 1369 .
熊殷 , 吴嘉瑞 , 张程亮 . 壮骨关节丸致肝损伤的研究进展 [J ] . 中南药学 , 2019 , 17 ( 12 ): 2084 - 2087 .
ZHANG L , WANG T , ZHAO BS , et al . Effect of 2″- O -rhamnosyl icariside Ⅱ,baohuoside Ⅰ and baohuoside Ⅱ in herba epimedii on cytotoxicity indices in HL-7702 and HepG2 cells [J ] . Molecules , 2019 , 24 ( 7 ): 1263 .
ZHAO Z , DU JF , WANG QL , et al . An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro [J ] . Food Chem Toxicol , 2023 , 176 : 113785 .
徐佳伟 , 尤雯雯 . 淫羊藿苷对人肝癌HepG2细胞的作用及其机制研究 [J ] . 中西医结合肝病杂志 , 2023 , 33 ( 1 ): 47 - 50 .
王婧 . 《黄帝内经》“有故无殒”理论的文献研究 [D ] . 北京 : 北京中医药大学 , 2009 .
张林 , 张晶璇 , 范琼尹 , 等 . 均匀设计结合多元回归分析用于淫羊藿对大鼠肝毒性的影响 [J ] . 中国实验方剂学杂志 , 2018 , 24 ( 6 ): 189 - 197 .
张林 , 康倩君 , 涂灿 , 等 . 朝鲜淫羊藿潜在肝毒性成分在不同种属肝微粒体中体外代谢稳定性研究 [J ] . 中华中医药杂志 , 2023 , 38 ( 11 ): 5469 - 5473 .
张林 , 王停 , 徐子瑛 , 等 . 基于网络毒理学预测和细胞生物学验证的淫羊藿潜在肝毒性成分与机制研究 [J ] . 中国中药杂志 , 2021 , 46 ( 10 ): 2413 - 2423 .
ZHANG L , XU AL , YANG S , et al . In vitro screening and toxic mechanism exploring of leading components with potential hepatotoxicity of Herba Epimedii extracts [J ] . Toxicol In Vitro , 2020 , 62 : 104660 .
李威 , 王顺谱 , 杨凤云 . 肾阳虚证动物模型建立方法及评定标准研究进展 [J ] . 江西中医药 , 2021 , 52 ( 8 ): 74 - 76 .
王志鑫 , 崔艳艳 , 宋婷婷 , 等 . 三种肾阴虚证动物模型造模方法比较研究 [J ] . 山东中医药大学学报 , 2023 , 47 ( 3 ): 323 - 329 .
张海宇 , 邸莎 , 张培 , 等 . 淫羊藿临床用量探析 [J ] . 吉林中医药 , 2018 , 38 ( 12 ): 1446 - 1449 .
蔡佳宇 , 常文静 , 蔡辉 . 论《黄帝内经》“有故无殒,亦无殒”的含义及临床意义 [J ] . 中医学报 , 2017 , 32 ( 1 ): 60 - 63 .
刘传鑫 , 孔娇 . 体质毒理学:中药安全性评价的新方向 [J ] . 世界科学技术-中医药现代化 , 2023 , 25 ( 12 ): 3776 - 3784 .
路爱梅 , 曲华 , 李洪峥 , 等 . 中医学“有故无殒”理论科学内涵和现代研究进展 [J ] . 中国中西医结合杂志 , 2023 , 43 ( 6 ): 764 - 766 .
徐虎军 , 王丽平 , 欧莉 , 等 . “有故无殒”法则下基于线粒体能量代谢途径的制首乌肝毒性机制研究 [J ] . 中药药理与临床 , 2019 , 35 ( 3 ): 82 - 87 .
王艳辉 , 赵海平 , 王伽伯 , 等 . 基于“有故无殒”思想的熟大黄对肝脏量-毒/效关系研究 [J ] . 中国中药杂志 , 2014 , 39 ( 15 ): 2918 - 2923 .
张天娇 . 基于“有故无殒”理论评价雷公藤甲素对荷瘤小鼠的肝毒性反应 [D ] . 北京 : 北京中医药大学 , 2017 .
邢玉瑞 . “有故无殒亦无殒”思想古今应用探讨 [J ] . 中国中医基础医学杂志 , 2020 , 26 ( 8 ): 1045 - 1046 .
0
浏览量
100
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621